New data demonstrates the impact of patents in Ukraine
News Research2020 will be remembered for COVID-19. The scale of the pandemic highlights the urgent need to ensure equitable access to...
Read more about New data demonstrates the impact of patents in Ukraine
-
Report: 10 years of community-monitoring of ARV procurement in Russia
News ResearchITPCru has released its latest report, providing a yearly analysis of community-monitoring of ARV procurement. The 2019 report marks 10...
Read more about Report: 10 years of community-monitoring of ARV procurement in Russia
-
COVID-19 pandemic: ‘An opportunity of a lifetime’?
News Research The race is on to find an effective treatment and vaccine for COVID-19. Everyone hopes a solution will be...
Read more about COVID-19 pandemic: ‘An opportunity of a lifetime’?
-
Global headlines: Potential COVID-19 drugs are over-priced
News ResearchFrom the front page of Le Monde, to the Financial Times, Bloomberg, Al Jazeera and others, research demonstrating that potential...
Read more about Global headlines: Potential COVID-19 drugs are over-priced
-
Possible treatments for COVID-19 could all be made for $1 a day, say researchers: Pharma must not profit from a pandemic and countries must ACT NOW.
Call to action News ResearchDrugs currently being used in COVID-19 treatment trials can all be mass-produced affordably, research from the University of Liverpool, published...
-
ITPC’s Global Survey on Access to and Quality of HIV Treatment and Care
News ResearchITPC’s Global Survey on Access to and Quality of HIV Treatment and Care focused on barriers to quality HIV care...
Read more about ITPC’s Global Survey on Access to and Quality of HIV Treatment and Care
-
Watch What Matters: Communities transforming healthcare
News Research VideoWhen the Community Treatment Observatories (CTOs) were first set up in 11 countries in West Africa to monitor access to...
Read more about Watch What Matters: Communities transforming healthcare
-
-
The right to health is compulsory: Time for action on dolutegravir – now!
Call to action News ResearchWhy Algeria, Azerbaijan, Belarus, Brazil, Bulgaria, China, Colombia, Kazakhstan, Mexico, Romania, Russia, and Turkey must issue compulsory licences on dolutegravir...
Read more about The right to health is compulsory: Time for action on dolutegravir – now!
-
